Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v7-FR | Version v5-EN | |
---|---|---|
Language | French | English |
Date Updated | 2020-09-30 | 2020-07-25 |
Drug Identification Number | 02240255 | 02240255 |
Brand name | ADACEL | ADACEL |
Common or Proper name | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed |
Company Name | SANOFI PASTEUR LIMITED | SANOFI PASTEUR LIMITED |
Ingredients | FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID PERTACTIN DIPHTHERIA TOXOID TETANUS TOXOID FIMBRIAE TYPES 2 AND 3 | FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID PERTACTIN DIPHTHERIA TOXOID TETANUS TOXOID FIMBRIAE TYPES 2 AND 3 |
Strength(s) | 5MCG 2.5MCG 3MCG 2LF 5LF 5MCG | 5MCG 2.5MCG 3MCG 2LF 5LF 5MCG |
Dosage form(s) | SUSPENSION | SUSPENSION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1 x 0.5 mL vial and 5 x 0.5 mL vials | 1 x 0.5 mL vial and 5 x 0.5 mL vials |
ATC code | J07AJ | J07AJ |
ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | 2020-07-24 | 2020-07-24 |
Actual start date | 2020-07-24 | 2020-07-24 |
Estimated end date | 2021-03-31 | 2021-03-31 |
Actual end date | 2020-09-29 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | Reason for Shortage: Due to delays in manufacturing and shipment of product for Canada | Allocation plan in place to meet public market demand; product not available for private market | Reason for Shortage: Due to delays in manufacturing and shipment of product for Canada | Allocation plan in place to meet public market demand; product not available for private market |
Health Canada comments |